|
|
Issue 13, 2010
HOT TOPICS IN RESPIRATORY MEDICINE
Influenza A (H1N1): the disease, its treatment and prevention
| Publ. date: | 2010 |
| ISBN: | 978-88-6450-044-7 |
| ISSN: | 1973-9664 |
| E-ISSN: | 2036-0886 |
| DOI: | 10.4147/HTR-091300 |
Abstract
Since this monograph has no abstract, we have provided an extract of the first 100 words of the first article.
Influenza is caused by infection with an influenza virus, which may result in disease of varying severity and death in a wide variety of animals and humans. Besides the annually recurring seasonal flu outbreaks in humans in temperate climate zones, influenza is probably best known for its ability to cause pandemics — that is, worldwide outbreaks of influenza in humans — with probably the best known and most terrifying example being the ‘Spanish flu’ that started in 1918 and killed more than 50 million people worldwide. Although it was Shope [1] who first isolated an influenza virus from pigs in 1930, it […]
Table of contents
Foreword
The 21st Century is the era of globalization. People can travel between countries and continents in a matter of hours or days, and, with those people, infective agents can also be disseminated at unprecedented speeds. One example is the influenza A (H1N1) virus. Since the first alarm in Mexico in early 2009, the pathogen spread quickly worldwide such that in less than 2 months 160 countries experienced both mild and severe disease caused by the new virus. National and international health agencies responded quickly, amassing and transmitting detailed scientific knowledge of this new pandemic. Six months was sufficient time to understand the clinical behavior of the disease and its severity worldwide. This issue of Hot Topics in Respiratory Medicine is dedicated to this new pandemic. As of November 15, 2009, there were approximately 622,000 laboratory-confirmed cases of pandemic influenza A (H1N1) worldwide, including at least 7826 deaths. Using mathematical modeling, the United States Centers for Disease Control and Prevention (CDC) has estimated that around 4000 fatal cases occurred in the United States between April 2009 and mid-October 2009. These figures created alarm in the Northern Hemisphere as winter approached. A massive vaccination campaign was begun at the end of 2009 and, fortunately, the incidence and severity of the influenza have not been as serious as expected. The reasons for this milder disease are not clear, and we still have lessons to learn from the epidemiology of this new virus. The three articles in this issue provide timely insight into the dissemination of this new strain of influenza A (H1N1) virus, the clinical manifestations of the disease it causes, and the preventive strategies that have helped to reduce the risk of a greater pandemic. This is one more page in the history of new pandemics. More pandemics will certainly come, so we need to be ready to take action in the future, when the increasing human population and intercontinental travel may facilitate the rapid spread of other, old or new, pathogens around the globe.
ARTICLES
The epidemiology of influenza viruses in humans
Pieter L.A. Fraaij, Albert D.M.E. Osterhaus
Clinical manifestations of influenza A (H1N1)
Oliver Pérez Bautista, Alejandra Ramírez Venegas, Raúl H. Sansores
Influenza A. Prevention and treatment
Gernot Rohde
If you have a Username and Password, you may already access to this article. Please login below.
If you do not have a Username and Password, click the "Register" button below to purchase this article.
|
 |
|
 |
| |
Editor-in-chief
Marc Miravitlles - MD
Over the last 15 years there has been a decrease in mortality due to preventable diseases, with the exception of chronic obstructive pulmonary disease (COPD), which is an example that highlights the r...
[EDITORS:PAST:TITLE]
[EDITORS:PAST:LIST]
|
|
|
|
|
|
| |
|
|
|